The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized phase II study with dendritic cell (DC) immunotherapy in patients with resected hepatic metastasis of colorectal carcinoma.
Javier Rodriguez
No relevant relationships to disclose
Ruth Vera
No relevant relationships to disclose
Fernando Pardo
No relevant relationships to disclose
Javier Herrera
No relevant relationships to disclose
Ana Chopitea
No relevant relationships to disclose
Irene Hernandez
No relevant relationships to disclose
Antonio Viudez
No relevant relationships to disclose
Carlos Garzon
No relevant relationships to disclose
Carlos Alfaro
No relevant relationships to disclose
Jose Luis Perez-Gracia
No relevant relationships to disclose
Alberto Benito
No relevant relationships to disclose
Alvaro Gonzalez
No relevant relationships to disclose
Ivan Peñuelas
No relevant relationships to disclose
Maria Rodriguez-Ruiz
No relevant relationships to disclose
Miguel F. Sanmamed
No relevant relationships to disclose
Carmen Oñate
No relevant relationships to disclose
Carmen Ochoa
No relevant relationships to disclose
Juan Pablo Fusco
No relevant relationships to disclose
Ignacio Melero
No relevant relationships to disclose